Genetics References Clinical studies Fra(X)(p22) not associated with infantile autism. Lancet 1984; 2

:)


Download 0.6 Mb.
Page10/12
Date conversion29.03.2017
Size0.6 Mb.
1   ...   4   5   6   7   8   9   10   11   12

Rett syndrome

1. Abuhatzira L, Makedonski K, Galil YP, Gak E, Ben Zeev B, Razin A et al. Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis. Hum Genet 2005; 118(1): 91-98.


2. Akbarian S, Chen RZ, Gribnau J, Rasmussen TP, Fong H, Jaenisch R et al. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis 2001; 8(5): 784-791.
3. Akefeldt A, Ekman R, Gillberg C, Mansson JE. Cerebrospinal fluid monoamines in Prader-Willi syndrome. Biol Psychiatry 1998; 44(12): 1321-1328.
4. Akesson HO, Hagberg B, Wahlstrom J. Rett syndrome, classical and atypical: genealogical support for common origin. J Med Genet 1996; 33(9): 764-766.
5. Akesson HO, Hagberg B, Wahlstrom J. Rett syndrome: presumptive carriers of the gene defect. Sex ratio among their siblings. Eur Child Adolesc Psychiatry 1997; 6 Suppl 1: 101-102.
6. Akesson HO, Hagberg B, Wahlstrom J, Engerstrom IW. Rett syndrome: a search for gene sources. Am J Med Genet 1992; 42(1): 104-108.

7. Akesson HO, Wahlstrom J, Engerstrom IW, Hagberg B. Rett syndrome: potential gene sources--phenotypical variability. Clin Genet 1995; 48(4): 169-172.

8. Alembik Y, Dott B, Stoll C. Rett-like syndrome in fragile X syndrome. Genet Couns 1995; 6(3): 207-210.
9. Alvarez-Nava F, Gonzalez-Ferrer S, Soto M. [Diagnosis and management of patients with sex differentiation disorders: experience at the Unit of Medical Genetics of the University of Zulia, Maracaibo, Venezuela]. Invest Clin 1998; 39(4): 273-292.
10. Amano K, Nomura Y, Segawa M, Yamakawa K. R133C and R168X mutations in Japanese Rett syndrome patients: a caution for misdiagnosis. Brain Dev 2001; 23 Suppl 1: S152-156.
11. Amir R, Dahle EJ, Toriolo D, Zoghbi HY. Candidate gene analysis in Rett syndrome and the identification of 21 SNPs in Xq. Am J Med Genet 2000; 90(1): 69-71.
12. Amir RE, Fang P, Yu Z, Glaze DG, Percy AK, Zoghbi HY et al. Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J Med Genet 2005; 42(2): e15.
13. Amir RE, Sutton VR, Van den Veyver IB. Newborn screening and prenatal diagnosis for Rett syndrome: implications for therapy. J Child Neurol 2005; 20(9): 779-783.

14. Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 2000; 47(5): 670-679.

15. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23(2): 185-188.
16. Amir RE, Zoghbi HY. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 2000; 97(2): 147-152.
17. Anvret M, Johansson IM, Wahlstrom J, Hagberg B. Linkage analysis of the Rett syndrome using human chromosomal specific probes. Brain Dev 1985; 7(3): 361-364.
18. Anvret M, Wahlstrom J. Rett syndrome: random X chromosome inactivation. Clin Genet 1994; 45(5): 274-275.
19. Anvret M, Wahlstrom J, Skogsberg P, Hagberg B. Segregation analysis of the X-chromosome in a family with Rett syndrome in two generations. Am J Med Genet 1990; 37(1): 31-35.
20. Anvret M, Zhang ZP, Hagberg B. Rett syndrome: the bcl-2 gene--a mediator of neurotrophic mechanisms? Neuropediatrics 1994; 25(6): 323-324.

21. Archer H, Evans J, Leonard H, Colvin L, Ravine D, Christodoulou J et al. Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 2007; 44(2): 148-152.

22. Archer HL, Evans JC, Millar DS, Thompson PW, Kerr AM, Leonard H et al. NTNG1 mutations are a rare cause of Rett syndrome. Am J Med Genet A 2006; 140(7): 691-694.
23. Archer HL, Whatley SD, Evans JC, Ravine D, Huppke P, Kerr A et al. Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J Med Genet 2006; 43(5): 451-456.
24. Archidiacono N, Lerone M, Rocchi M, Anvret M, Ozcelik T, Francke U et al. Rett syndrome: exclusion mapping following the hypothesis of germinal mosaicism for new X-linked mutations. Hum Genet 1991; 86(6): 604-606.
25. Archidiacono N, Rett A, Rocchi M, Rolando S, Lugaresi E, Romeo G. Rett syndrome and fragile site in Xp22. Lancet 1985; 2(8466): 1242-1243.
26. Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A et al. FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008; 83(1): 89-93.

27. Ariani F, Mari F, Pescucci C, Longo I, Bruttini M, Meloni I et al. Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication. Hum Mutat 2004; 24(2): 172-177.

28. Armstrong J, Pineda M, Aibar E, Gean E, Monros E. Classic Rett syndrome in a boy as a result of somatic mosaicism for a MECP2 mutation. Ann Neurol 2001; 50(5): 692.
29. Armstrong J, Pineda M, Monros E. Mutation analysis of 16S rRNA in patients with Rett syndrome. Pediatr Neurol 2000; 23(1): 85-87.
30. Auber B, Burfeind P, Thiels C, Alsat EA, Shoukier M, Liehr T et al. An unbalanced translocation resulting in a duplication of Xq28 causes a Rett syndrome-like phenotype in a female patient. Clin Genet 2010; 77(6): 593-597.
31. Augenstein K, Lane JB, Horton A, Schanen C, Percy AK. Variable phenotypic expression of a MECP2 mutation in a family. J Neurodev Disord 2009; 1(4): 313.
32. August GJ, Lockhart LH. Familial autism and the fragile-X chromosome. J Autism Dev Disord 1984; 14(2): 197-204.
33. Auranen M, Vanhala R, Vosman M, Levander M, Varilo T, Hietala M et al. MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology 2001; 56(5): 611-617.
34. Ausio J, Levin DB, De Amorim GV, Bakker S, Macleod PM. Syndromes of disordered chromatin remodeling. Clin Genet 2003; 64(2): 83-95.

35. Bahi-Buisson N, Nectoux J, Girard B, Van Esch H, De Ravel T, Boddaert N et al. Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant. Neurogenetics 2010; 11(2): 241-249.

36. Ballestar E, Ropero S, Alaminos M, Armstrong J, Setien F, Agrelo R et al. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum Genet 2005; 116(1-2): 91-104.
37. Ballestar E, Yusufzai TM, Wolffe AP. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 2000; 39(24): 7100-7106.
38. Bao XH, Pan H, Song FY, Wu XR. [Clinical feature of Rett syndrome and MeCP2 genotype/phenotype correlation analysis]. Zhonghua Er Ke Za Zhi 2004; 42(4): 252-255.
39. Bapat S, Galande S. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome. Bioessays 2005; 27(7): 676-680.
40. Bartholdi D, Klein A, Weissert M, Koenig N, Baumer A, Boltshauser E et al. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene. Clin Genet 2006; 69(4): 319-326.

41. Bebbington A, Anderson A, Ravine D, Fyfe S, Pineda M, de Klerk N et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology 2008; 70(11): 868-875.

42. Bebbington A, Percy A, Christodoulou J, Ravine D, Ho G, Jacoby P et al. Updating the profile of C-terminal MECP2 deletions in Rett syndrome. J Med Genet 2010; 47(4): 242-248.
43. Beck DJ, Brubaker RR. Mutagenic properties of cis-plantinum(II)diammino-dichloride in Escherichia coli. Mutat Res 1975; 27(2): 181-189.
44. Bienvenu T, Souville I, Poirier K, Aquaviva C, Burglen L, Amiel J et al. Five novel frameshift mutations in exon 3 and 4 of the MECP2 gene identified in Rett patients: Consequences for the molecular diagnosis strategy. Hum Mutat 2001; 18(3): 251-252.
45. Bienvenu T, Villard L, De Roux N, Bourdon V, Fontes M, Beldjord C et al. Spectrum of MECP2 mutations in Rett syndrome. Genet Test 2002; 6(1): 1-6.
46. Borg I, Freude K, Kubart S, Hoffmann K, Menzel C, Laccone F et al. Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome. Eur J Hum Genet 2005; 13(8): 921-927.
47. Borghgraef M, Fryns JP, Dielkens A, Pyck K, Van den Berghe H. Fragile (X) syndrome: a study of the psychological profile in 23 prepubertal patients. Clin Genet 1987; 32(3): 179-186.

48. Bourdon V, Philippe C, Bienvenu T, Koenig B, Tardieu M, Chelly J et al. Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications. J Med Genet 2001; 38(12): 867-871.

49. Bourdon V, Philippe C, Grandemenge A, Reichwald K, Jonveaux P. Deletion screening by fluorescence in situ hybridization in Rett syndrome patients. Ann Genet 2001; 44(4): 191-194.
50. Bourdon V, Philippe C, Labrune O, Amsallem D, Arnould C, Jonveaux P. A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum Genet 2001; 108(1): 43-50.
51. Bourdon V, Philippe C, Martin D, Verloes A, Grandemenge A, Jonveaux P. MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implications. Mol Diagn 2003; 7(1): 3-7.
52. Brodkin ES. Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008). Behav Neurosci 2008; 122(2): 483-489.
53. Buoni S, Zannolli R, De Felice C, De Nicola A, Guerri V, Guerra B et al. EEG features and epilepsy in MECP2-mutated patients with the Zappella variant of Rett syndrome. Clin Neurophysiol 2010; 121(5): 652-657.

54. Buoni S, Zannolli R, Felice CD, Saponari S, Strambi M, Dotti MT et al. Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome. Clin Neurophysiol 2008; 119(11): 2455-2458.

55. Buschdorf JP, Stratling WH. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J Mol Med (Berl) 2004; 82(2): 135-143.
56. Buyse IM, Fang P, Hoon KT, Amir RE, Zoghbi HY, Roa BB. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet 2000; 67(6): 1428-1436.
57. Buyse IM, Roa BB. Denaturing high-performance liquid chromatography and sequence analyses for MECP2 mutations in Rett syndrome. Methods Mol Biol 2003; 217: 119-130.
58. Bzduch V, Zahorakova D, Grechanina E, Zdibskaja EP, Goldfarb IG, Zeman J et al. A case of Rett syndrome from Ukraine--clinical diagnosis confirmed by mutation analysis of the MECP2 gene. Bratisl Lek Listy 2004; 105(9): 299-302.
59. Camus P, Abbadi N, Perrier MC, Chery M, Gilgenkrantz S. X chromosome inactivation in 30 girls with Rett syndrome: analysis using the probe. Hum Genet 1996; 97(2): 247-250.
60. Carvalho CM, Camargos W, Pena SD. Multiplex protocol suitable for screening for MECP2 mutations in girls with mental retardation. Clin Chem 2006; 52(3): 539-540.

61. Chae JH, Hwang H, Hwang YS, Cheong HJ, Kim KJ. Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype. J Child Neurol 2004; 19(7): 503-508.

62. Chae JH, Hwang YS, Kim KJ. Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome. J Child Neurol 2002; 17(1): 33-36.
63. Charman T, Neilson TC, Mash V, Archer H, Gardiner MT, Knudsen GP et al. Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype-phenotype associations in Rett syndrome. Eur J Hum Genet 2005; 13(10): 1121-1130.
64. Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 2000; 9(7): 1119-1129.
65. Chunshu Y, Endoh K, Soutome M, Kawamura R, Kubota T. A patient with classic Rett syndrome with a novel mutation in MECP2 exon 1. Clin Genet 2006; 70(6): 530-531.
66. Clarke A, Gardner-Medwin D, Richardson J, McGann A, Bonham JR, Carpenter KH et al. Abnormalities of carbohydrate metabolism and of OCT gene function in the Rett syndrome. Brain Dev 1990; 12(1): 119-124.
67. Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V et al. Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis 2001; 8(5): 847-865.

68. Coleman M, Naidu S, Murphy M, Pines M, Bias W. A set of monozygotic twins with Rett syndrome. Brain Dev 1987; 9(5): 475-478.

69. Conforti FL, Mazzei R, Magariello A, Patitucci A, Gabriele AL, Muglia M et al. Mutation analysis of the MECP2 gene in patients with Rett syndrome. Am J Med Genet A 2003; 117A(2): 184-187.
70. Cummings CJ, Dahle EJ, Zoghbi HY. Analysis of the genomic structure of the human glycine receptor alpha2 subunit gene and exclusion of this gene as a candidate for Rett syndrome. Am J Med Genet 1998; 78(2): 176-178.
71. Curtis AR, Headland S, Lindsay S, Thomas NS, Boye E, Kamakari S et al. X chromosome linkage studies in familial Rett syndrome. Hum Genet 1993; 90(5): 551-555.
72. Dayer AG, Bottani A, Bouchardy I, Fluss J, Antonarakis SE, Haenggeli CA et al. MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev 2007; 29(1): 47-50.
73. De Bona C, Zappella M, Hayek G, Meloni I, Vitelli F, Bruttini M et al. Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet 2000; 8(5): 325-330.
74. Delgado IJ, Kim DS, Thatcher KN, LaSalle JM, Van den Veyver IB. Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients. BMC Med Genet 2006; 7: 61.

75. Delobel B, Delannoy V, Pini G, Zapella M, Tardieu M, Vallee L et al. Identification and molecular characterization of a small 11q23.3 de novo duplication in a patient with Rett syndrome manifestations. Am J Med Genet 1998; 80(3): 273-280.

76. Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S et al. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 2007; 16(6): 640-650.
77. Deutscher K, Deutscher J, Bergmann L, Tefs K, Reichwald K, Schuster V. [Clinical and molecular genetic findings in four girls with Rett syndrome]. Klin Padiatr 2002; 214(5): 291-294.
78. Djarmati A, Dobricic V, Kecmanovic M, Marsh P, Jancic-Stefanovic J, Klein C et al. MECP2 mutations in Serbian Rett syndrome patients. Acta Neurol Scand 2007; 116(6): 413-419.
79. Dragich J, Houwink-Manville I, Schanen C. Rett syndrome: a surprising result of mutation in MECP2. Hum Mol Genet 2000; 9(16): 2365-2375.
80. Dykens EM. Psychopathology in children with intellectual disability. J Child Psychol Psychiatry 2000; 41(4): 407-417.
81. Dykens EM. Are jigsaw puzzle skills 'spared' in persons with Prader-Willi syndrome? J Child Psychol Psychiatry 2002; 43(3): 343-352.

82. Ellaway C, Buchholz T, Smith A, Leonard H, Christodoulou J. Rett syndrome: significant clinical overlap with Angelman syndrome but not with methylation status. J Child Neurol 1998; 13(9): 448-451.

83. Ellaway CJ, Badawi N, Raffaele L, Christodoulou J, Leonard H. A case of multiple congenital anomalies in association with Rett syndrome confirmed by MECP2 mutation screening. Clin Dysmorphol 2001; 10(3): 185-188.
84. Ellaway CJ, McQuade LR, Christodoulou J. Novel mitochondrial 16S rRNA polymorphism in a girl with Rett syndrome. J Inherit Metab Dis 1999; 22(8): 946-947.
85. Ellison KA, Fill CP, Terwilliger J, DeGennaro LJ, Martin-Gallardo A, Anvret M et al. Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet 1992; 50(2): 278-287.
86. Ellison KA, Roth EJ, McCabe ER, Chinault AC, Zoghbi HY. Isolation of a yeast artificial chromosome contig spanning the X chromosomal translocation breakpoint in a patient with Rett syndrome. Am J Med Genet 1993; 47(7): 1124-1134.
87. Erlandson A, Hallberg B, Hagberg B, Wahlstrom J, Martinsson T. MECP2 mutation screening in Swedish classical Rett syndrome females. Eur Child Adolesc Psychiatry 2001; 10(2): 117-121.

88. Erlandson A, Samuelsson L, Hagberg B, Kyllerman M, Vujic M, Wahlstrom J. Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. Genet Test 2003; 7(4): 329-332.

89. Evans JC, Archer HL, Colley JP, Ravn K, Nielsen JB, Kerr A et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet 2005; 13(10): 1113-1120.
90. Evans JC, Archer HL, Whatley SD, Clarke A. Germline mosaicism for a MECP2 mutation in a man with two Rett daughters. Clin Genet 2006; 70(4): 336-338.
91. Evans JC, Archer HL, Whatley SD, Kerr A, Clarke A, Butler R. Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. Eur J Hum Genet 2005; 13(1): 124-126.
92. Fehr S, Downs J, Bebbington A, Leonard H. Atypical presentations and specific genotypes are associated with a delay in diagnosis in females with Rett syndrome. Am J Med Genet A 2010; 152A(10): 2535-2542.
93. Fendri-Kriaa N, Abdelkafi Z, Rebeh IB, Kamoun F, Triki C, Fakhfakh F. A novel MECP2 gene mutation in a Tunisian patient with Rett syndrome. Genet Test Mol Biomarkers 2009; 13(1): 109-113.
94. Fendri-Kriaa N, Mkaouar-Rebai E, Moalla D, Belguith N, Louhichi N, Zemni R et al. Mutational analysis of the MECP2 gene in Tunisian patients with Rett syndrome: a novel double mutation. J Child Neurol 2010; 25(8): 1042-1046.

95. Ferlini A, Ansaloni L, Nobile C, Forabosco A. Molecular analysis of the Rett syndrome using cDNA synapsin I as a probe. Brain Dev 1990; 12(1): 136-139.

96. Ferrari P. [Multidisciplinary approach to autism and early childhood psychoses]. Neuropsychiatr Enfance Adolesc 1983; 31(5-6): 225-237.
97. Feuk L, Kalervo A, Lipsanen-Nyman M, Skaug J, Nakabayashi K, Finucane B et al. Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am J Hum Genet 2006; 79(5): 965-972.
98. Fichou Y, Nectoux J, Bahi-Buisson N, Rosas-Vargas H, Girard B, Chelly J et al. The first missense mutation causing Rett syndrome specifically affecting the MeCP2_e1 isoform. Neurogenetics 2009; 10(2): 127-133.
99. Fong CB, Thong MK, Sam CK, Mohamed Noor MN, Ariffin R. MECP2 mutations in Malaysian Rett syndrome patients. Singapore Med J 2009; 50(5): 529-533.
100. Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R et al. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet 2010; 19(16): 3114-3123.

101. Fukuda T, Yamashita Y, Nagamitsu S, Miyamoto K, Jin JJ, Ohmori I et al. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Dev 2005; 27(3): 211-217.

102. Gamerdinger U, Eggermann T, Schubert R, Schwanitz G, Kreiss-Nachtsheim M. Rare interstitial deletion 9q31.2 to q33.1 de novo: longitudinal study in a patient over a period of more than 20 years. Am J Med Genet A 2008; 146A(9): 1180-1184.
103. Gartler SM, Varadarajan KR, Luo P, Canfield TK, Traynor J, Francke U et al. Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteins. BMC Biol 2004; 2: 21.
104. Giampietro PF, Schowalter DB, Merchant S, Campbell LR, Swink T, Roa BB. Widened clinical spectrum of the Q128P MECP2 mutation in Rett syndrome. Childs Nerv Syst 2006; 22(3): 320-324.
105. Gibson JH, Williamson SL, Arbuckle S, Christodoulou J. X chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype. Brain Dev 2005; 27(4): 266-270.
106. Gill H, Cheadle JP, Maynard J, Fleming N, Whatley S, Cranston T et al. Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome. J Med Genet 2003; 40(5): 380-384.

107. Gillberg C, Wahlstrom J, Hagberg B. A "new" chromosome marker common to the Rett syndrome and infantile autism? The frequency of fragile sites at X p22 in 81 children with infantile autism, childhood psychosis and the Rett syndrome. Brain Dev 1985; 7(3): 365-367.

108. Girard M, Couvert P, Carrie A, Tardieu M, Chelly J, Beldjord C et al. Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet 2001; 9(3): 231-236.
109. Giunti L, Pelagatti S, Lazzerini V, Guarducci S, Lapi E, Coviello S et al. Spectrum and distribution of MECP2 mutations in 64 Italian Rett syndrome girls: tentative genotype/phenotype correlation. Brain Dev 2001; 23 Suppl 1: S242-245.
110. Glaze DG, Percy AK, Skinner S, Motil KJ, Neul JL, Barrish JO et al. Epilepsy and the natural history of Rett syndrome. Neurology 2010; 74(11): 909-912.
111. Gomot M, Gendrot C, Verloes A, Raynaud M, David A, Yntema HG et al. MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype-genotype correlation. Am J Med Genet A 2003; 123A(2): 129-139.

112. Gordon K, Siu VM, Sergovich F, Jung J. 18q-mosaicism associated with Rett syndrome phenotype. Am J Med Genet 1993;


1   ...   4   5   6   7   8   9   10   11   12
:)


The database is protected by copyright ©hestories.info 2017
send message

    Main page

:)